Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis.
D000477:Alkylating Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008212:Lymphocyte Depletion; D010956:Plasmapheresis; D013897:Thoracic Duct
D000477:Alkylating Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents